[1] Hodson EM,Craig JC.Therapies for steroid-resistant nephrotie syndrome[J].Pediatr Nep,2008,23(9):1391-1394. [2] Chen C,Chin JE,Ueda K,et al.Internal duplication and homology with bacterial transport proteins in the MDR1(P-glycoprotein) gene from multidrug-resistant human cells [J].Cell,1986,47(3):381-389. [3] A T,P G,MR D,et al.Glucocorticoid effects on changes in bonemineral density andcortical structure in childhood nephrotic syndrome [J].J Bone Min Res,2013,28(3):480-488. [4] Stachowski J,anker CB,Runowski D,et al.Resistance to therapy in primary nephrotic syndrome:effect of MDR1 gene activity [J].Pol Merkuriusz Lek,2000,46(8):218-221. [5] Kodaira C,Sugimoto M,Nishino M,et al.Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects[J].Eur J Clin Pharmacol,2009,65(6):593-600. [6] Wasilewska A,Zoch-Zwierz W,Pietruczuk M.Expression of multidrug resistance P-glycoprotein on Lymphocytess from nephrotic children treated with cyclosporine A and ACE-inhibitor[J].Eur J Pediatr,2007,166(5):447-452.
2018, Vol. 35 
